Schonfeld Strategic Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,414	Closed	-$87.1K	–	2789
2026 Q1	$87.1K	Buy	+35,414	New	+$119K	﹤0.01%	1908
2022 Q1	–	Sell	-4,230	Closed	-$200K	–	2736
2021 Q4	$200K	Sell	4,230 -129,500	-97%	-$7.77M	﹤0.01%	1730
2021 Q3	$9.69M	Buy	133,730 +114,630	+600%	+$8.29M	0.1%	264
2021 Q2	$1.6M	Sell	19,100 -51,151	-73%	-$3.37M	0.02%	784
2021 Q1	$3.4M	Buy	+70,251	New	+$3.81M	0.04%	535
2020 Q2	–	Sell	-18,735	Closed	-$244K	–	1374
2020 Q1	$244K	Buy	+18,735	New	+$234K	0.02%	836

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Schonfeld Strategic Advisors's NBP Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 35,414 shares — an estimated $87.1K sold.

Schonfeld Strategic Advisors first reported a position in NBP in Q1 2020 and held it in 6 quarters. The position peaked at $9.69M in Q3 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Schonfeld Strategic Advisors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
Schonfeld Strategic Advisors sold 35,414 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $87.1K.
Schonfeld Strategic Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 6 quarters.
Schonfeld Strategic Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $9.69M in Q3 2021.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.